“…Its use has been investigated in adult experimental animals and in human adults, children, and neonates. THAM has been shown to produce and in crease in pH and a decrease in paCCF [1-3, 8, 9] under most conditions, with a frequent finding of either hypoventilation or apnea [1,4,10,11], This has been attributed to the decrease in paCCF, causing depression of the respiratory center, and has prompted the rec ommendation of the use of mechanical venti lation along with THAM administration [12]. Hyperosmolality was reported in nephrectomized animals [13] and in human infants given THAM by rapid bolus infusion [3], Oth er side effects reported are hyperkalemia [6] and hypoglycemia [14], THAM was also shown to increase the oxygen affinity of adult whole blood in vitro [15], Because of these concerns, as well as the paucity of data on THAM pharmacokinetics, THAM has been used less frequently in recent years.…”